A new study reveals that only 37% of the US population is eligible to donate blood, with approximately 60 million fewer individuals being eligible than previously thought. The lower donor pool estimate is based on a more stringent model that excludes high-risk individuals and those with chronic diseases.
Testicular cancer patients with metastatic disease can be cured with high-dose chemotherapy and a stem cell transplant, as shown in an Indiana University School of Medicine report. The treatment, which involves carboplatin chemotherapy at five times the standard dosage, has a success rate of over 90%.
A joint research by Dr. Leonid Brodsky and Dr. Milton Taylor identified 37 genes out of 22,000 possible genes which fight the hepatitis C virus. The study's mathematical model can be applied to identify key genes in patient response to treatment, potentially leading to more effective medications.
Scientists have developed a method to amplify vCJD prions from human brain tissue extracts, enabling recognition by existing detection methods. This breakthrough could aid in confirming whether someone is infected with variant CJD, crucial for preventing further disease spread through infected blood donations.
Researchers have developed a method to amplify prions from brain tissue samples using normal blood cells, improving detection test sensitivity. This breakthrough may lead to a blood test for screening individuals at risk of passing variant CJD through blood transfusion or surgery.
R. Edward Coleman received the award for his contributions to molecular imaging and nuclear medicine practice, particularly in advancing positron emission tomography (PET) for breast cancer, Alzheimer's, and brain tumors. His research has had a significant impact on medicine, and he is recognized as one of the best doctors in America.
Michael R. Zalutsky received the award for his significant contributions to medical science, especially in using molecular targeting to combat cancer. His research has had a substantial impact on therapeutic nuclear medicine and its applications.
A Phase III study suggests ALIMTA-carboplatin may deliver less toxicity than GEMZAR-carboplatin, offering comparable quality-of-life benefits and survival data. The combination also appears to benefit from a lower toxicity profile.
Researchers analyzed data on blood donations and recipients in Sweden and Denmark over 34 years, finding no link between cancer risk and blood from precancerous donors. The study provides valuable insights into the safety of blood transfusions and highlights the need for further research on chronic diseases.
A new animal study investigates three methods of treatment for severe internal injuries, with HBOC-201 resuscitation showing improved survival rates. The study's findings suggest targeting a Mean Arterial Pressure of 80 mmHg is more favorable than a target MAP of 100 mmHg.
A new study by Dr. Jacques Lacroix found that a restrictive transfusion strategy can be as safe as a liberal strategy in stable, critically ill children without increasing adverse outcomes. This approach reduced the need for transfusions and improved health care outcomes for pediatric ICU patients.
A phase III trial of darbepoetin alfa found that the drug did not reduce blood transfusion risk in non-chemotherapy patients, but increased overall patient mortality. Patients with certain types of cancer saw better survival outcomes when treated with the drug.
A $12.5 million grant from Charles Bronfman will establish the Charles Bronfman Institute for Personalized Medicine, transforming medical practice with genomics-based strategies for disease detection and treatment. The gift will seed a $30 million initiative to advance personalized medicine at Mount Sinai.
A University of Rochester study concludes that filtering white cells from donor blood before a transfusion is much safer for patients and long overdue as a national standard. The practice reduces post-surgical infection rates by 30%, saving lives and reducing costs nationwide.
A landmark five-year study explores the under-representation of women and minority faculty in leadership and senior positions in academic medicine. The National Initiative on Gender, Culture and Leadership in Medicine aims to foster the advancement of women and minority physicians in academic medicine.
A new benchmark study finds that timeliness is a critical factor in the success of treatment for twin-twin transfusion syndrome (TTTS). The study, led by Dr. Timothy Crombleholme, highlights the importance of early diagnosis and aggressive intervention to improve survival rates. Fetal echocardiography is recommended as a crucial diagno...
A study presented at the American Society of Hematology Meeting shows Revlimid can provide long-term durable results in MDS patients, helping them achieve blood transfusion independence. After over two years of follow-up, two-thirds of patients were completely freed from the need for blood transfusions.
A new case of variant Creutzfeldt-Jakob disease (vCJD) linked to a blood transfusion has been confirmed in the UK. The patient developed symptoms six years after receiving a contaminated blood sample from a donor who later died from vCJD. Early diagnosis and monitoring are crucial for affected individuals.
A study of over 44,000 patients found that blood transfusions were associated with a benefit in those with low hematocrit levels but harm in others. For patients with moderate hematocrit levels, transfusions showed no benefit or harm, suggesting providers may reconsider their decision-making process.
Patients with peripheral arterial disease (PAD) undergoing interventional heart procedures are at higher risk for dying within a week and experiencing complications such as blood clots and bleeding. The study analyzed nearly 20,000 patients and found PAD to be a strong predictor of life or death in these cases.
A Phase II trial of Revlimid found that over 75% of MDS patients reduced their need for transfusions, with two-thirds completely freed from transfusions. In 45% of cases, no detectable cancer was found after treatment.
The Society of Nuclear Medicine and Molecular Imaging emphasizes the beneficial aspects of nuclear medicine, a highly effective diagnostic and treatment method. Every major hospital has a nuclear medicine department, performing over 19 million procedures annually, increasing by 15% from four years ago.
The risk of transfusion-transmitted infections has decreased significantly since 1984 due to improved blood-safety measures. However, emerging pathogens such as variant Creutzfeldt-Jakob disease and viruses present in high concentrations in blood pose ongoing concerns for patient safety.
A Phase III efficacy study led by Dr. Peter Hillmen found eculizumab significantly improves anaemia and quality of life in patients with paroxysmal nocturnal haemoglobinuria (PNH). The treatment also reduces intravascular hemolysis, fatigue, pain, and shortness of breath.
Mount Sinai Journal of Medicine will transition to Wiley, focusing on translational and personalized medicine, featuring articles on clinical care, bio-medical research, and patient outcomes. The journal's redesign aims to bridge the gap between scientific discovery and clinical application.
A transfusion-free surgical program for Jehovah's Witness patients undergoing liver transplantation has significantly reduced the overall use of blood products for non-Jehovah's Witnesses. The program's implementation led to lower mean number of intraoperative PRBC and FFP transfusions, as well as decreased procedure cost.
Regenerative medicine holds promise for affordable treatments and offsetting donor shortages, particularly for diabetes, heart disease, and infectious diseases. The study prioritizes 10 applications, including novel insulin replacement methods, regenerating failed heart muscle, and engineered immune cells.
The Pall eBDS System is a highly sensitive culture-based test that detects bacterial contamination of red blood cells, reducing the risk of sepsis and death from transfusion. The system's novel approach to detection measures oxygen consumption as a marker for bacteria, allowing for effective detection of commonly found contaminants.
Researchers developed a non-invasive Doppler ultrasonography method to detect fetal anemia in high-risk pregnancies. The study found that this new procedure is safer than traditional testing methods, which can be traumatic for the mother and carry a risk of miscarriage.
The FDA approves REVLIMID(R) (lenalidomide) for treating patients with multiple myeloma who have received at least one prior therapy. Key findings include a higher risk of hematologic toxicity and thromboembolic events in patients receiving the combination treatment.
The IU School of Medicine has received a $8.9 million grant to expand its HIV/AIDS programs in Kenya. The program, AMPATH, will provide anti-retroviral drug treatments to over 18,000 people by September 2007 and screen more than 25,000 pregnant women annually.
Daniel Guarasci, a clinical assistant professor at State University of New York at Buffalo, has been honored with the SNMTS Outstanding Educator Award. He translates complex information into understandable language for students, positively influencing nuclear medicine technology students.
A new artificial preservative has increased the storage period of blood platelets to 7 days, reducing the need for frequent transfusions and lowering the risk of adverse reactions. This innovation could have significant global implications for patients in critical need of platelet transfusions.
A Canadian Blood Services scientist has developed a potential alternative to costly IVIg treatment, which could lead to more effective and safer therapies for patients with life-threatening illnesses. The synthetic product could also reduce production costs and increase availability.
A recent study suggests that women with acute coronary syndromes should not be denied access to cardiac catheterization laboratories, particularly high-risk patients. The research analyzed data from over 1,000 women and found that outcomes for women were similar to those of men in terms of mortality and heart attack rates.
A new study suggests that an individual's unique genetic makeup can affect their risk of developing severe anemia from malaria. Researchers have identified specific genes and DNA sequences that control the production of MIF, a protein linked to malarial anemia.
Researchers at Duke University Medical Center developed a new formula to predict blood needs in heart surgery, focusing on patient age, weight, and kidney function. The simplified scoring system identifies risk factors for transfusion, aiming to reduce hospital resources and staff time.
An interdisciplinary team of scientists and physicians has developed guidelines for treating severely injured patients, focusing on inflammation response and genetic factors. The project aims to improve patient care through standard treatment procedures and tailored treatments based on genetic data.
The study found that middle-aged donors (40-59 years old) are the largest group, representing 45% of all donors. E-mail reminders and 'Bring a Friend Day' events will be used to engage young donors in the future.
Research finds blood type and age may be pivotal in transfusion success. Blood transfusions are associated with a markedly increased risk of mortality in patients suffering from ST-elevation myocardial infarction.
Researchers found that retreatment with decitabine resulted in 45% of patients achieving any response, with some experiencing partial or complete remission. The median overall survival was 28 months, and continued outpatient maintenance treatment is being studied for its benefits.
Researchers found decitabine improves disease-free periods, quality of life in MDS patients. New drug offers little survival benefit but improves quality of life and has some quality of life benefits compared to supportive care.
59% of general internists, 60% of subspecialists participated to improve professional image and update medical knowledge. The survey also found that 69% of general internists believed board-certified physicians are more competent than non-certified ones.
A recent study found that stopping regular blood transfusions in children with sickle cell disease who are at risk for a stroke means their stroke risk likely returns. The study, which involved 41 children, showed that within a few months of halting transfusion, 14 children resumed at-risk status and two had strokes.
In the Phase 2 study, Aranesp demonstrated a significant erythroid response and improvements in hemoglobin levels and fatigue among low-risk MDS patients. The study found that 70% of patients with no prior erythropoietic agent use achieved an erythroid response and 67% reached target hemoglobin levels.
Research at Duke University Medical Center found that US heart patients receive blood transfusions 84% more often than Europeans and 38% more often than Asians. The study revealed wide differences in bleeding and transfusion rates among heart patients globally, with the US having significantly higher rates.
Researchers found high HCV rates among former plasma/blood donors and villagers who received blood transfusions. Unhygienic plasma donation and blood transfusion are strong risk factors for HCV infection in rural central China.
Prestoraged pooled platelets have been shown to have an equivalent clinical response and quality to platelets pooled at the time of transfusion, increasing platelet availability and reducing hospital costs. The Pall eBDS System has demonstrated high sensitivity in detecting bacteria in pooled platelets.
A new study found that red blood cells filtered through the Pall Leukotrap Affinity Prion Reduction Filter System retain their therapeutic value and quality after 42 days of storage, exceeding FDA requirements. The filter demonstrated a 99.9% reduction of prions, including sporadic CJD, scrapie, and mouse-adapted human vCJD.
The ACP Expert Guide to Sports Medicine covers assessment and management of common musculoskeletal injuries and other sports-related conditions. The book is organized in three sections: Overview, Medical Conditions (non-musculoskeletal), and Musculoskeletal Injuries, with tables, illustrations, and case studies.
A Hopkins study successfully performed 21 out of 22 KPD transplants, showing the technique can offer transplants to many more patients who cannot receive a kidney from a loved one. The results could pave the way for a national matching registry and help hundreds of patients find compatible matches.
A Canadian study found that severe maternal morbidity rates declined between 1991 and 2001, with lower rates of postpartum hemorrhage requiring transfusion. However, a significant increase in uterine rupture cases was observed during this period, with women who experienced these complications being 158 times more likely to die.
A Phase 2 study of Aranesp(R) demonstrates a 77% overall response rate in low-risk MDS patients with anemia. Patients who had never received erythropoietic therapy responded well to Aranesp, while those with prior treatment showed continued efficacy.
The International Campaign to Revitalise Academic Medicine proposes three possible futures for academic medicine: one driven by the private sector, another by public engagement, and a third by global networks. The scenarios offer insights into how academic medicine should evolve, with potential benefits including improved efficiency, i...
A new study confirms the filter's effectiveness in reducing prions by up to 99.9%, providing a critical safety measure against vCJD transmission through blood transfusion. The technology has the potential to safeguard the global blood supply and prevent future outbreaks.
Jan Winn, associate professor at the University of Oklahoma Health Sciences Center, has been honored with the Outstanding Educator Award by the Society of Nuclear Medicine Technologist Section. She is praised for her ability to explain complex concepts and incorporate new information into her classes.
Scientists have discovered that Rh proteins, previously thought to be inactive carriers, play a crucial role in facilitating the transfer of carbon dioxide in and out of red blood cells. This finding has significant implications for our understanding of human physiology, including breathing, pH regulation, and kidney function.
A study found that nearly all US physicians in six high-risk specialties reported practicing defensive medicine, with common practices including ordering unnecessary tests and referring patients for consultation. Defensive medicine may reduce access to care and pose risks of physical harm, particularly in women's health.
A new study published in the American College of Radiology shows that expandable electrodes are safe and effective for radiofrequency ablation of liver tumors. The procedure resulted in high survival rates and low complication rates, comparable to those achieved through surgery.
Recent studies have shown a significant decrease in multiple organ failure (MOF) incidence among severely injured patients over the last decade. Advances in trauma and critical care, including more judicious use of blood transfusions, have led to improved MOF outcomes.